Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association

Sarah D. De Ferranti, Julia Steinberger, Rebecca K Ameduri, Annette Baker, Holly Gooding, Aaron S Kelly, Michele Mietus-Snyder, Mark M. Mitsnefes, Amy L. Peterson, Julie St-Pierre, Elaine M. Urbina, Justin P. Zachariah, Ali N. Zaidi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis. For each topic, the evidence for accelerated acquired coronary artery disease and stroke in childhood and adolescence and the evidence for benefit of interventions in youth will be reviewed. Children and adolescents may be at higher risk for cardiovascular disease because of significant atherosclerotic or arteriosclerotic risk factors, high-risk conditions that promote atherosclerosis, or coronary artery or other cardiac or vascular abnormalities that make the individual more vulnerable to the adverse effects of traditional cardiovascular risk factors. Existing scientific statements and guidelines will be referenced when applicable, and suggestions for risk identification and reduction specific to each setting will be described. This statement is directed toward pediatric cardiologists, primary care providers, and subspecialists who provide clinical care for these young patients. The focus will be on management and justification for management, minimizing information on pathophysiology and epidemiology.

Original languageEnglish (US)
Pages (from-to)E603-E634
JournalCirculation
Volume139
Issue number13
DOIs
StatePublished - Mar 26 2019

Fingerprint

Risk Reduction Behavior
Pediatrics
Atherosclerosis
Cardiovascular Diseases
Information Management
Arteriosclerosis
Blood Vessels
Coronary Artery Disease
Primary Health Care
Coronary Vessels
Patient Care
Epidemiology
Stroke
Guidelines

Keywords

  • AHA Scientific Statements
  • adolescence
  • cardiovascular diseases
  • pediatrics
  • risk management
  • risk reduction

PubMed: MeSH publication types

  • Journal Article

Cite this

Cardiovascular Risk Reduction in High-Risk Pediatric Patients : A Scientific Statement From the American Heart Association. / De Ferranti, Sarah D.; Steinberger, Julia; Ameduri, Rebecca K; Baker, Annette; Gooding, Holly; Kelly, Aaron S; Mietus-Snyder, Michele; Mitsnefes, Mark M.; Peterson, Amy L.; St-Pierre, Julie; Urbina, Elaine M.; Zachariah, Justin P.; Zaidi, Ali N.

In: Circulation, Vol. 139, No. 13, 26.03.2019, p. E603-E634.

Research output: Contribution to journalArticle

De Ferranti, SD, Steinberger, J, Ameduri, RK, Baker, A, Gooding, H, Kelly, AS, Mietus-Snyder, M, Mitsnefes, MM, Peterson, AL, St-Pierre, J, Urbina, EM, Zachariah, JP & Zaidi, AN 2019, 'Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association', Circulation, vol. 139, no. 13, pp. E603-E634. https://doi.org/10.1161/CIR.0000000000000618
De Ferranti, Sarah D. ; Steinberger, Julia ; Ameduri, Rebecca K ; Baker, Annette ; Gooding, Holly ; Kelly, Aaron S ; Mietus-Snyder, Michele ; Mitsnefes, Mark M. ; Peterson, Amy L. ; St-Pierre, Julie ; Urbina, Elaine M. ; Zachariah, Justin P. ; Zaidi, Ali N. / Cardiovascular Risk Reduction in High-Risk Pediatric Patients : A Scientific Statement From the American Heart Association. In: Circulation. 2019 ; Vol. 139, No. 13. pp. E603-E634.
@article{dd7c2f10417b4b9188e9014555bdc064,
title = "Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association",
abstract = "This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis. For each topic, the evidence for accelerated acquired coronary artery disease and stroke in childhood and adolescence and the evidence for benefit of interventions in youth will be reviewed. Children and adolescents may be at higher risk for cardiovascular disease because of significant atherosclerotic or arteriosclerotic risk factors, high-risk conditions that promote atherosclerosis, or coronary artery or other cardiac or vascular abnormalities that make the individual more vulnerable to the adverse effects of traditional cardiovascular risk factors. Existing scientific statements and guidelines will be referenced when applicable, and suggestions for risk identification and reduction specific to each setting will be described. This statement is directed toward pediatric cardiologists, primary care providers, and subspecialists who provide clinical care for these young patients. The focus will be on management and justification for management, minimizing information on pathophysiology and epidemiology.",
keywords = "AHA Scientific Statements, adolescence, cardiovascular diseases, pediatrics, risk management, risk reduction",
author = "{De Ferranti}, {Sarah D.} and Julia Steinberger and Ameduri, {Rebecca K} and Annette Baker and Holly Gooding and Kelly, {Aaron S} and Michele Mietus-Snyder and Mitsnefes, {Mark M.} and Peterson, {Amy L.} and Julie St-Pierre and Urbina, {Elaine M.} and Zachariah, {Justin P.} and Zaidi, {Ali N.}",
year = "2019",
month = "3",
day = "26",
doi = "10.1161/CIR.0000000000000618",
language = "English (US)",
volume = "139",
pages = "E603--E634",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Cardiovascular Risk Reduction in High-Risk Pediatric Patients

T2 - A Scientific Statement From the American Heart Association

AU - De Ferranti, Sarah D.

AU - Steinberger, Julia

AU - Ameduri, Rebecca K

AU - Baker, Annette

AU - Gooding, Holly

AU - Kelly, Aaron S

AU - Mietus-Snyder, Michele

AU - Mitsnefes, Mark M.

AU - Peterson, Amy L.

AU - St-Pierre, Julie

AU - Urbina, Elaine M.

AU - Zachariah, Justin P.

AU - Zaidi, Ali N.

PY - 2019/3/26

Y1 - 2019/3/26

N2 - This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis. For each topic, the evidence for accelerated acquired coronary artery disease and stroke in childhood and adolescence and the evidence for benefit of interventions in youth will be reviewed. Children and adolescents may be at higher risk for cardiovascular disease because of significant atherosclerotic or arteriosclerotic risk factors, high-risk conditions that promote atherosclerosis, or coronary artery or other cardiac or vascular abnormalities that make the individual more vulnerable to the adverse effects of traditional cardiovascular risk factors. Existing scientific statements and guidelines will be referenced when applicable, and suggestions for risk identification and reduction specific to each setting will be described. This statement is directed toward pediatric cardiologists, primary care providers, and subspecialists who provide clinical care for these young patients. The focus will be on management and justification for management, minimizing information on pathophysiology and epidemiology.

AB - This scientific statement presents considerations for clinical management regarding the assessment and risk reduction of select pediatric populations at high risk for premature cardiovascular disease, including acquired arteriosclerosis or atherosclerosis. For each topic, the evidence for accelerated acquired coronary artery disease and stroke in childhood and adolescence and the evidence for benefit of interventions in youth will be reviewed. Children and adolescents may be at higher risk for cardiovascular disease because of significant atherosclerotic or arteriosclerotic risk factors, high-risk conditions that promote atherosclerosis, or coronary artery or other cardiac or vascular abnormalities that make the individual more vulnerable to the adverse effects of traditional cardiovascular risk factors. Existing scientific statements and guidelines will be referenced when applicable, and suggestions for risk identification and reduction specific to each setting will be described. This statement is directed toward pediatric cardiologists, primary care providers, and subspecialists who provide clinical care for these young patients. The focus will be on management and justification for management, minimizing information on pathophysiology and epidemiology.

KW - AHA Scientific Statements

KW - adolescence

KW - cardiovascular diseases

KW - pediatrics

KW - risk management

KW - risk reduction

UR - http://www.scopus.com/inward/record.url?scp=85063712770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063712770&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000618

DO - 10.1161/CIR.0000000000000618

M3 - Article

C2 - 30798614

AN - SCOPUS:85063712770

VL - 139

SP - E603-E634

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 13

ER -